D. Roychowdhury

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Hans von der Maase, Steen Werner Hansen, J.T. Roberts et al. · Journal of Clinical Oncology · 2000 · 2.3K citations · Full text

Health-Related Quality-of-Life Parameters as Independent Prognostic Factors in Advanced or Metastatic Bladder Cancer

D. Roychowdhury, A. Hayden, Astra M. Liepa · Journal of Clinical Oncology · 2003 · 119 citations

First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study

Olavo Feher, P Vodvářka, Jacek Jassem et al. · Annals of Oncology · 2005 · 93 citations

Metastatic Breast Cancer, Oncology, Breast Oncology +8

Results of an analysis of cardiac function in 2,812 patients treated with lapatinib

EA Perez, Julie Byrne, Isaac W. Hammond et al. · Journal of Clinical Oncology · 2006 · 40 citations

Cardiac Function, Heart Failure, Cardiovascular Pharmacology +17

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Hans von der Maase, Steen Werner Hansen, J.T. Roberts et al. · Journal of Clinical Oncology · 2023 · 39 citations · Full text